After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
EOLS belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Evolus Inc is $413.99M. A total of 0.53 million shares were traded on the day, compared to an average of 1.39M shares.
In the most recent transaction, Yamagishi-Dressler Tomoko sold 5,722 shares of EOLS for 7.51 per share on Aug 22 ’25. After the transaction, the Chief Marketing Officer now owns 89,949 company shares. In a previous transaction on Aug 15 ’25, Stewart Brady bought 30,000 shares at 6.82 per share. EOLS shares that Director owns now total 88,629.
Among the insiders who sold shares, MOATAZEDI DAVID disposed of 111,323 shares on Jun 13 ’25 at a per-share price of $10.05. This resulted in the insider holding 381,509 shares of EOLS after the transaction. In another insider transaction, MOATAZEDI DAVID sold 16,582 shares at $9.89 per share on Jun 16 ’25. Company shares held by the insider now total 364,927.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EOLS has a high of $17.49 and a low of $5.71.
As of this writing, EOLS has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.19. The company reported an EPS of -$0.18 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EOLS’s latest balance sheet shows that the firm has $146.26M in Cash & Short Term Investments as of fiscal 2021. There were $74.74M in debt and $57.66M in liabilities at the time. Its Book Value Per Share was -$0.29, while its Total Shareholder’s Equity was $81.88M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EOLS is Buy with a score of 4.43.
